4-O-Methyl honokiol structure
|
Common Name | 4-O-Methyl honokiol | ||
---|---|---|---|---|
CAS Number | 68592-15-4 | Molecular Weight | 280.36100 | |
Density | 1.054g/cm3 | Boiling Point | 396.5ºC at 760 mmHg | |
Molecular Formula | C19H20O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 176.2ºC |
Use of 4-O-Methyl honokiol4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. |
Name | 2-(4-methoxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol |
---|---|
Synonym | More Synonyms |
Description | 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. |
---|---|
Related Catalog | |
Target |
PPARγ NF-κB |
In Vitro | 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity. 4-O-Methyl honokiol (20 μM) increases the expression, transcription and DNA binding activities, and nuclear translocation of PPARγ in both in prostate PC-3 and LNCap cells. 4-O-Methyl honokiol (0-30 μM) inhibits LNCaP and PC-3 cancer cells growth, causes G0/G1 phase arrest and induces apoptotic cell death, and such effects can be reversed by PPARγ antagonist. 4-O-Methyl honokiol inhibits NF-κB activity and cancer cell growth, but such effects as well as its activation of PPARγ can be abolished by knock-down of p21[1]. 4-O-methylhonokiol (0.5, 1 and 2 μM) reduces LPS-induced release of NO, PGE2, ROS, TNF-α and IL-1β in cultured astrocytes, and amyloidogenesis in cultured astrocytes and microglial BV-2 cells[2]. |
In Vivo | 4-O-Methyl honokiol (40 or 80 mg/kg, i.p. everyday for 4 weeks) inhibits the growth of SW620 and PC3 tumours in SW620 and PC3 xenograft model. 4-O-Methyl honokiol significantly increases the expression of p21 and PPARγ in the tumour tissues[1]. 4-O-Methyl honokiol (0.5 or 1 mg/kg/day daily for 3 weeks) significantly ameliorates LPS-induced memory impairment, and inhibits LPS-induced iNOS and COX-2 expression in mice. 4-O-Methyl honokiol also shows inhibitory activities against the Aβ1-42 accumulation, and activates astrocytes and microglia in LPS-injected mice brain[2]. |
Cell Assay | Cells (5 × 104 cells per well) are plated onto 24-well plates. The cell growth inhibitory effect of 4-O-Methyl honokiol is evaluated in cells treated with 4-O-Methyl honokiol (0-30 μM) for 0-72 h, using an excluded trypan blue assay[1]. |
Animal Admin | Six-week-old male BALB/c athymic nude mice are used in the assay. SW620 and PC3 cells are injected s.c. (1 × 107 cells in 0.1 mL PBS per animal) into the lower right flanks of mice. After 20 days, when the tumours have reached an average volume of 300-400 mm3 or about 50 mm3, the tumour-bearing nude mice are i.p. injected with 4-O-Methyl honokiol (40 and 80 mg/kg dissolved in 0.1% DMSO) twice per week for 3 weeks. Cisplatin (10 mg/kg) is also i.p. injected once a week as a positive control. The group treated with 0.1% DMSO is designated as the control. The tumour volumes are measured with vernier calipers and calculated by the following formula: (A × B2)/2, where A is the larger and B is the smaller of the two dimensions[1]. |
References |
Density | 1.054g/cm3 |
---|---|
Boiling Point | 396.5ºC at 760 mmHg |
Molecular Formula | C19H20O2 |
Molecular Weight | 280.36100 |
Flash Point | 176.2ºC |
Exact Mass | 280.14600 |
PSA | 29.46000 |
LogP | 4.52480 |
Index of Refraction | 1.569 |
Storage condition | 2-8℃ |
Precursor 9 | |
---|---|
DownStream 4 | |
3,5'-diallyl-2'-hydroxy-4-methoxy-1,1'-biphenyl |
4'-O-Methylhonokiol |
3,5'-diallyl-2'-hydroxy-4-methoxybiphenyl |
METHYLHONOKIOL |
methoxyhonokiol |
4-methoxyhonokiol |
4-O-Methyl honokiol |